Neurol. praxi. 2021;22(6):519-522 | DOI: 10.36290/neu.2021.112

Creutzfeldt-Jakobov disease: clinical case report

MUDr. Petr Nohel1, prof. MUDr. Radoslav Matěj, Ph.D.2
1 Neurologické oddělení Nemocnice ve Frýdku-Místku
2 Národní referenční laboratoř pro diagnostiku lidských TSE/CJD (NRL TSE/CJD) při Oddělení patologie Fakultní Thomayerovy nemocnice, Praha

Sporadic Creutzfeldt-Jacob disease (sCJD) is rare, prion and incurable disease. It is characterized by the rapid development of dementia and other focal symptoms. Typical signs of CJD are found in the MR examination of the brain, in the EEG and in the examination of cerebrospinal fluid. The definitive diagnosis is determined by neuropathological examination of brain tissue. We present the case of an elderly man with sudden onset and rapidly progressing dementia and characteristic findings in auxiliary examination methods. Neuropathological changes in the brain eventually demonstrated changes typical of Creutzfeldt-Jakob disease, but also of frontotemporal lobar degeneration with tau positive inclusions.

Keywords: Creutzfeldt-Jacob disease, dementia, prion diseases.

Published: December 9, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nohel P, Matěj R. Creutzfeldt-Jakobov disease: clinical case report. Neurol. praxi. 2021;22(6):519-522. doi: 10.36290/neu.2021.112.
Download citation

References

  1. CDC's Diagnostic Criteria for Creutzfeldt-Jakob Disease (CJD) [online]. 2018 [cit. 2020-10-28]. Dostupné z: https://www.cdc.gov/prions/cjd/diagnostic-criteria.html.
  2. Fragoso DC, Gonçalves Filho ALM, Pacheco FT, Barros BR, Aguiar Littig I, Nunes RH, Maia Júnior ACS, Da Rocha A. Imaging of Creutzfeldt-Jakob Disease: Imaging Patterns and Their Differential Diagnosis. RadioGraphics [online]. 2017; 37(1): 234-257 [cit. 2020-08-03]. DOI: 10.1148/rg.2017160075. ISSN 0271-5333. Dostupné z: http://pubs.rsna.org/doi/10.1148/rg.2017160075. Go to original source... Go to PubMed...
  3. Matěj R. Vyšetřování proteinu 14-3-3 v mozkomíšním moku - klinicko-patologická korelace. Česká a slovenská neurologie a neurochirurgie. 2008; 2008(6): 695-699. ISSN 1210-7859.
  4. Mcguire LI, Alexander H, Peden CH, Orrú D, Wilham, JM, Appleford NE, Mallinson G, Andrews M, Head MW, Caughey B, Will RG, Knight RSG, Green AJE. Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Annals of Neurology [online]. 2012; 72(2): 278-285 [cit. 2020-10-28]. ISSN 03645134. Dostupné z: doi: 10.1002/ana.23589. Go to original source... Go to PubMed...
  5. Mitrová E. Prionove choroby a ich aktualny epidemiologicky vyznam. Neurol. praxi 2007; 3: 143-144.
  6. Prusiner SB. The prion diseases. Brain Pathol. 1998; 8(3): 499-513. Go to original source... Go to PubMed...
  7. Rossi M, Kai H, Baiardi S, Bartoletti-Stella A, Carlà B, Zenesini C, Capellari S, Kitamoto T, Parchi P. The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins. Acta Neuropathologica Communications [online]. 2019, 7(1) [cit. 2020-08-24]. DOI: 10.1186/s40478-019-0706-6. ISSN 2051-5960. Dostupné z: https://actaneurocomms.biomedcentral.com/articles/10.1186/s40478-019-0706-6. Go to original source... Go to PubMed...
  8. Rusina R, Matěj R. Prionová onemocnění. Neurol. praxi 2012; 13(2): 78-82.
  9. Vališ M. Tau-protein, Fosforylovaný tau-protein a beta-amyloid42 v likvoru u demencí a roztroušené sklerózy. Česká a slovenská neurologie a neurochirurgie 2008; 2008(3): 329-335.
  10. Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heineman U, Breithaupt M, Varges D, Meissner B, Ladogana, A, Schuur M, Haik S,, Collins SJ, Jansen GH, Stokin GB, Pimentel, J, Hewer E, Coliie D, Smith P, Roberts H, Brandel JP, van Duijn, C, Pocchiari M, Begue C, Cras P, Will RG, Sanchez-Juan P. Updated, clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009; 132(Pt10): 2659-2668. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.